Satya Therapeutics Celebrates Milestones as Oregon's Leading Psilocybin Service Provider

ASHLAND, OR / ACCESS Newswire / April 10, 2025 / Satya Therapeutics, a pioneer in Oregon's psilocybin therapy landscape, today announced significant achievements underscoring its leadership in the state's growing psychedelic wellness sector.

Client Volume and Industry Impact

The company recently conducted its 900th client session, positioning itself as one of Oregon's most active service centers. With an estimated 8% of all clients served statewide since the program's 2023 launch, Satya continues to set benchmarks in accessibility and care. In Q1 2025 alone, the center welcomed 129 clients, reflecting sustained demand despite industry and economic uncertainties.

Affordability and Vertical Integration

Satya's $1,000 all-inclusive sessions-among Oregon's most affordable - are made possible by its vertically integrated model. The company grows its own psilocybin mushrooms, ensuring quality control and cost efficiency. Andreas Met, COO, emphasized: "Our direct cultivation allows us to offer exceptional value while maintaining rigorous safety standards".

Accolades and Facilitator Expertise

The center (and facilitator Shelah Wind-Smith) recently earned its 100th 5-star Google review, a rare feat given regulatory restrictions on soliciting client feedback. CEO Jennifer Met noted: "These organic testimonials reflect our team's commitment to compassionate, professional care". Several facilitators have now guided 100+ clients each, a milestone unmatched in the nascent industry.

Facilitator Milestones

Satya's facilitators have achieved remarkable milestones, with several having guided 100 or more clients. This level of experience is unparalleled in the industry, where seeing even 40 clients is considered a significant achievement. The following facilitators at Satya have reached this threshold, demonstrating their exceptional expertise and dedication to client care:

Andreas Met highlighted: "By the time a facilitator has seen 100 clients, their experience level is truly world-class in this young industry. We are proud of our team's commitment to delivering high-quality care and look forward to continuing to support their professional growth."

Manufacturing Innovation

Satya's manufacturing license renewal by the OHA (approved April 1, 2025) enables continued production of proprietary psilocybin blends, including the "Melange" series designed for clients using SSRIs/antipsychotics. The company supplies psilocybin at $1 per milligram wholesale - Oregon's lowest verified rate.

Contextualizing Oregon's Psilocybin Landscape

As Oregon's program enters its third year, Satya's growth aligns with statewide trends:

• 8,000+ clients served across 31 licensed centers

• 356 state-licensed facilitators operating

• Pending 2025 legislation to improve care continuity and provider licensure

About Satya Therapeutics
Founded in 2020 and headquartered in Medford, Oregon, Satya Inc. operates Ashland's Satya Therapeutics - a state-licensed psilocybin service center prioritizing safety, accessibility, and client-focused innovation.

Media Contact
Andreas Met, COO
541-930-2478 | andreas@satyatherapeutics.com
www.satyatherapeutics.com

Editors' Note: Psilocybin remains a Schedule I substance under federal law. Oregon's program operates under state Measure 109 (2020) for supervised therapeutic use only.

SOURCE: SATYA INC.